News

Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup
The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations ...
Monthly weight loss drug helps people lose 20% of body weight, trial finds
A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
Novo Nordisk Stock Sinks as Latest Weight-Loss Drug Trial Disappoints
Novo Nordisk's U.S.-listed shares fell more than 5% Monday after the drugmaker revealed the latest results for a new weight-loss treatment.
Novo Nordisk's Weight Loss Injection CagriSema Data Sparks Investors Concern
Novo Nordisk's CagriSema achieved significant weight loss in phase 3 trials, though safety concerns may limit its edge over ...
Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects
Novo Nordisk on Sunday said full results from two late-stage trials of its experimental weight-loss drug CagriSema show that ...